Ann: Prescient Therapeutics Investor Briefing, page-19

I'm a strong believer in underpromise, overdeliver. Hopefully it isn't the other way around with SYC. Keeping shareholders in the dark about where their money is a bit of an ethical dilemma, so I hope for all stakeholder they're confident in success. Otherwise the board / directors have the potential to be charged in criminal court under new corporations act legislature. But that's me being negative.

By the sounds of it, we should see a stream of announcements over the remainder of the CY. Am excited for that and hopeful that trials are positive to the patients benefits.

Did anyone raise concerns around directors skin in the game? If they're talking it up and believe everything will be positive, surely they'd be looking to gain exposure for the long run? That's a stronger indicator to me then words out of someones mouth.

Short term will be interesting to see the SP performance tomorrow / remainder of the week.